Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: Evaluation in a large cohort of subjects assessed with the 1999 World Health Organization Criteria for the classification of diabetes

Metabolism: Clinical and Experimental

Volumn 52, Issue 5, 2003, Pages 616-619

  Moro, Ermanno ^a   Gallina, P ^a   Pais, M ^a   Cazzolato, G ^a   Alessandrini, P ^a   Bittolo Bon, G ^a  

^a Venice Regional Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CALCULATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION; BLOOD; CLASSIFICATION; DRUG EFFECT; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 0038410181     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50102     Document Type: Article

References (41)

1. Austin MA: Plasma trigliceride and coronary heart disease. Arterioscler Thromb 11:2-14, 1991
2. NIH Consensus Conference: Triglyceride, high-density lipoprotein and coronary heart disease. JAMA 269:505-510, 1993
3. Garber AM, Avins AL: Triglyceride concentration and coronary heart disease. BMJ 309:1440-1441, 1994
4. Criqui MH, Heiss G, Cohn R, et al: Plasma triglyceride level and mortality from coronary heart disease. N Eng J Med 328:1220-1225, 1993
5. Assmann G, Schulte H, Von Eckardstein A: Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77:1179-1184, 1996
6. Bainton D, Miller NE, Yarnell JWG, et al: Plasma triglyceride and high level density lipoprotein cholesterol as predictor of ischaemic heart disease in British men: The Caerphilly and Speedwell Collaborative Heart disease Studies. Br Heart J 68:60-66, 1992
7. Jeppesen J, Hein HO, Suadicani P, et al: Triglyceride concentration and ischaemic heart disease. An eight-year follow-up in the Copenhagen Male Study. Circulation 97:1029-1036, 1998
8. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
9. Pyorala K, Savolainen E, Kaukola S, et al: Plasma insulin as a coronary risk factor: Relationship to other risk and predictive value during 9 1/2-years follow-up of the Helsinki Policemen Study population. Acta Med Scand 701:38-52, 1985 (suppl)
10. Fontbonne AM, Eschwege EM: Insulin and cardiovascular disease: Paris Prospective Study. Diabetes Care 14:461-469, 1991
11. McKeigue PM, Ferrie JE, Pierpoint T, et al: Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 87:152-161, 1993
12. Ronnemaa T, Laakso M, Pyorola K, et al: High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects. Arterioscler Thromb 11:80-90, 1991
13. Modan M, Karasik A, Drory Y, et al: Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 84:1165-1175, 1991
14. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland, World Health Organization, 1999
15. Hermans MP, Levy JC, Morris RJ, et al: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678-687, 1999
16. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
17. Bonora E, Kiechl S, Willeit J, et al: Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 47:1643-1649, 1998
18. Philips DI, Clark PM, Hales CN, et al: Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994
19. Bray GA: An approach to the classification and evaluation of obesity, in Björntorp P, Brodoff BN (eds): Obesity. Philadelphia, PA, Lippincott 1992, pp 294-308
20. Kostner GM, Avogaro P, Bittolo-Bon G, et al: Determination of high-density lipoproteins: Screening methods compared. Clin Chem 25:939-942, 1979
21. Cambien F, Warmet JM, Eschewege E, et al: Body mass, blood pressure, glucose and lipids. Does plasma insulin explain their relationships? Arteriosclerosis 7:197-202, 1987
22. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
23. Tobey TA, Greenfield MS, Kraemer F, et al: Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma trygliceride levels in normotriglyceridemic man. Metabolism 30:165-171, 1981
24. McKane WR, Stevens AB, Woods R, et al: The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism 39:1240-1245, 1990
25. Ruige JB, Assendelft WJ, Dekker JM, et al: Insulin and risk of cardiovascular disease. A meta-analysis. Circulation 97:996-1001, 1998
26. Laakso M: Insulin resistance and coronary heart disease. Curr Opin Lipidol 7:217-226, 1996
27. Karhapaa P, Malkki M, Laakso M: Isolated low HDL cholesterol: An insulin resistance state. Diabetes 43:411-417, 1994
28. Zavaroni I, Dall'Aglio E, Alpi O, et al: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-266, 1985
29. Ahn YI, Ferrell RE, Hamman RF, et al: Association of lipoprotein lipase gene variation with the physiological components of the resistance syndrome in the population of the Saint Luis Valley, Colorado. Diabetes Care 16:1502-1506, 1993
30. Moller DE, Bjorbaek C, Vidal-Puig A: Candidate genes for insulin resistance. Diabetes Care 19: 396-400, 1996
31. Bartlett SM, Gibbons GF: Short- and long-term regulation of very-low-density-lipoprotein secretion by insulin, dexamethazone and lipogenic substrates in cultured hepatocytes: A biphasic effect of insulin. Biochem J 249:37-43, 1988
32. Lewis GF, Uffelman KD, Szeto L et al: Interaction between free fatty acids and insulin in the acute control of very density lipoprotein production in humans. J Clin Invest 95:158-166, 1995
33. Lewis GF, Zinman B, Uffelman KD, et al: VLDL production is decreased to a similar extent by acute portal and systemic hyperinsulinemia in humans. Am J Physiol 267:E566-E572, 1994
34. Lewis GF, Steiner G: Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 19:390-393, 1996
35. Lewis GF, Uffelman KD, Szeto LW, et al: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apo B production in normal weight and obese individuals. Diabetes 42:833-842, 1993
36. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
37. Hollenbeck CB, Chen N, Chen YD, et al: Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes 33:460-463, 1984
38. Saad MF, Anderson RL, Laws A, et al: The Insulin Resistance Atherosclerosis Study Group: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
39. Laakso M: How good marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
40. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart study. Diabetes Care 20:1087-1092, 1997
41. Haffner SM, Kennedy E, Gonzalez C, et al: A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19:1138-1141, 1996